United States · FDA National Drug Code directory

Glipizide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2614_ae0ed781-abbb-4f3b-b52f-4cefc655ce03
Product NDC
72162-2614
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Glipizide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20230303
Source listing expiry
20271231

Source-listed ingredients

  • GLIPIZIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2614-1) · 72162-2614-1
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2614-5) · 72162-2614-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →